More specifically, we wanted to study whether the down- and upregulation of Glo-1 expression exerts any impact on the expression of putative genes implicated in inflammation, oxidative stress, and endothelial dysfunction, under normoglycemic and hyperglycemic conditions in the micro- and macrovessels, respectively. Here, GLO1 is linked to endothelial dysfunction.